# Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation

> **NCT00985985** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 723 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Nicotine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00985985
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 723 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00985985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00985985, "Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00985985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*